BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lankenau Institute for Medical Research Awarded 5-Year Cancer Research Grant From the W.W. Smith Charitable Trust


9/4/2013 10:34:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Wynnewood, Pa. (September 4, 2013) - The Lankenau Institute for Medical Research (LIMR), the research arm of Main Line Health, has been awarded a 5-year, $625,000 grant from the W.W. Smith Charitable Trust to initiate promising avenues of cancer research.

“We are incredibly excited about the research opportunities that will be afforded through this grant,” states George Prendergast, Ph.D., President and CEO of LIMR.

Researchers at LIMR are currently developing breast cancer diagnostic tools to improve patient care and outcomes. One project involves identifying markers for early stage breast cancers that are thought to be curable through conventional avenues of treatment, but are not. Another test being developed will determine whether the toxicity from chemotherapy would be too severe for a patient before they need to be admitted to the hospital for chemotherapy complications.

“Main Line Health is committed to providing the best cancer care to our communities,” affirms Dr. Prendergast, “and thanks to the generous funding of the W.W. Smith Charitable Trust, LIMR scientists can contribute to cancer research and treatments that may lead to medical breakthroughs.”

About The W.W. Smith Charitable Trust

The W. W. Smith Charitable Trust is a private local foundation established by William Wikoff Smith in 1977. A primary focus of the Trust is to fund basic medical research in the areas of heart disease, cancer and AIDS. To learn more about the W.W. Smith Charitable Trust, please visit www.wwsmithcharitabletrust.org.

About Lankenau Institute for Medical Research

Founded in 1927, the Lankenau Institute for Medical Research (LIMR) is an independent, nonprofit biomedical research center located in suburban Philadelphia on the campus of Lankenau Medical Center. Part of Main Line Health, LIMR is one of the few freestanding, hospital associated medical research centers in the nation. The faculty and staff at the Institute are dedicated to advancing an understanding of the causes of cancer, heart disease and diabetes. This information is used to help improve diagnosis and treatment of these diseases as well as find ways to prevent them. LIMR is also committed to extending the boundaries of human health and well-being through technology development and the training of the next generation of scientists and physicians. To learn about LIMR, visit www.limr.org.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES